Despite remarkable advances in our understanding of myocarditis, the mechanisms that enable many patients to recover cardiac function remain incompletely understood. In a recent study published in Cardiovascular Research, Kametani and colleagues identify the Hippo pathway effector Yes-associated protein (YAP) as a key regulator of myocardial healing after myocarditis.
Using human myocardial samples together with an autoimmune myocarditis mouse model, the authors demonstrate that YAP is transiently activated in cardiomyocytes during the recovery phase. Loss of cardiomyocyte YAP impaired cardiac repair, resulting in increased apoptosis, fibrosis, oxidative stress, reduced angiogenesis, and persistent cardiac dysfunction. Mechanistically, YAP promoted recovery by suppressing IFN-γ/STAT1 signaling, a pathway well known for its pro-inflammatory effects. Importantly, inhibition of IFN-γ or cardiomyocyte-specific STAT1 knockdown mostly restored cardiac function, highlighting this signaling axis as a potential therapeutic target.
Beyond its established role in driving cardiomyocyte proliferation, this study highlights YAP as a key regulator of the intrinsic repair program of the heart. Via the IFN-γ/STAT1 signaling, YAP appears to create a more favorable environment for myocardial healing, suggesting that successful recovery depends not only on targeting inflammation but also on activating endogenous repair mechanisms.
Several challenges remain before these findings can be translated into clinical practice. YAP has pleiotropic effects in multiple cell types, and systemic activation could have unintended consequences, including unwanted proliferative responses. Future work will therefore need to determine how cardiomyocyte-specific modulation of the YAP–STAT1 axis can be achieved safely and whether these observations extend to viral myocarditis and human disease.
Nevertheless, this study provides an important mechanistic insight into why some hearts recover after myocarditis while others progress to inflammatory cardiomyopathy. By identifying YAP as a regulator of endogenous cardiac repair, it opens an exciting avenue for the development of therapies aimed not only at limiting injury but also at enhancing myocardial recovery.
